Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,831,000 | 10,514,000 | 9,672,000 | 13,334,000 | 12,266,000 |
| Depreciation Amortization | 4,104,000 | 3,666,000 | 3,158,000 | 2,939,000 | 2,774,000 |
| Income taxes - deferred | -607,000 | -39,000 | -836,000 | 356,000 | -436,000 |
| Accounts receivable | -763,000 | 83,000 | -883,000 | -195,000 | 511,000 |
| Other Working Capital | -959,000 | -969,000 | 1,523,000 | -858,000 | 1,339,000 |
| Other Operating Activity | 1,808,000 | 2,141,000 | 1,664,000 | 809,000 | 117,000 |
| Operating Cash Flow | $17,414,000 | $15,396,000 | $14,298,000 | $16,385,000 | $16,571,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,137,000 | -1,425,000 | -1,551,000 | -1,860,000 | -2,211,000 |
| Net Acquisitions | -835,000 | -4,486,000 | -2,797,000 | -1,269,000 | -2,470,000 |
| Purchase Of Investment | -18,923,000 | -13,434,000 | -29,882,000 | -15,788,000 | -10,040,000 |
| Sale Of Investment | 18,058,000 | 14,797,000 | 30,396,000 | 11,101,000 | 7,232,000 |
| Other Investing Activity | -266,000 | 38,000 | -778,000 | -38,000 | -109,000 |
| Investing Cash Flow | $-5,103,000 | $-4,510,000 | $-4,612,000 | $-7,854,000 | $-7,598,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,411,000 | 3,268,000 | 9,729,000 | 7,874,000 | 9,484,000 |
| Debt Issued | 3,607,000 | 45,000 | 4,470,000 | 1,118,000 | 9,000 |
| Debt Repayment | -1,593,000 | -804,000 | -16,000 | -32,000 | -219,000 |
| Common Stock Issued | 2,649,000 | 2,720,000 | 1,246,000 | 1,226,000 | 882,000 |
| Common Stock Repurchased | -3,538,000 | -12,919,000 | -2,525,000 | -2,797,000 | -2,130,000 |
| Dividend Paid | -7,286,000 | -6,614,000 | -6,156,000 | -5,804,000 | -5,327,000 |
| Other Financing Activity | -1,341,000 | -6,258,000 | -11,200,000 | -6,565,000 | -6,791,000 |
| Financing Cash Flow | $-6,091,000 | $-20,562,000 | $-4,452,000 | $-4,980,000 | $-4,092,000 |
| Exchange Rate Effect | -204,000 | 45,000 | -47,000 | -6,000 | 161,000 |
| Beginning Cash Position | 14,911,000 | 24,542,000 | 19,355,000 | 15,810,000 | 10,768,000 |
| End Cash Position | 20,927,000 | 14,911,000 | 24,542,000 | 19,355,000 | 15,810,000 |
| Net Cash Flow | $6,016,000 | $-9,631,000 | $5,187,000 | $3,545,000 | $5,042,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,414,000 | 15,396,000 | 14,298,000 | 16,385,000 | 16,571,000 |
| Capital Expenditure | -3,595,000 | -2,934,000 | -2,893,000 | -2,384,000 | -2,365,000 |
| Free Cash Flow | 13,819,000 | 12,462,000 | 11,405,000 | 14,001,000 | 14,206,000 |